Works matching AU PERKOVIC, VLADO
Results: 181
The effect of pentoxifylline on oxidative stress in chronic kidney disease patients with erythropoiesis-stimulating agent hyporesponsiveness: Sub-study of the HERO trial.
- Published in:
- Redox Report, 2016, v. 21, n. 1, p. 14, doi. 10.1179/1351000215Y.0000000022
- By:
- Publication type:
- Article
Canagliflozin, mental health adverse events and diabetes: Exploratory analysis of the CREDENCE trial and CANVAS Program.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 12, p. 2459, doi. 10.1111/dom.14832
- By:
- Publication type:
- Article
Canagliflozin and atrial fibrillation in type 2 diabetes mellitus: A secondary analysis from the CANVAS Program and CREDENCE trial and meta‐analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 10, p. 1927, doi. 10.1111/dom.14772
- By:
- Publication type:
- Article
Cardiovascular and renal outcomes with canagliflozin in patients with peripheral arterial disease: Data from the CANVAS Program and CREDENCE trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 6, p. 1072, doi. 10.1111/dom.14671
- By:
- Publication type:
- Article
Impact of random variation in albuminuria and estimated glomerular filtration rate on patient enrolment and duration of clinical trials in nephrology.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 6, p. 983, doi. 10.1111/dom.14660
- By:
- Publication type:
- Article
Reasons for hospitalizations in patients with type 2 diabetes in the CANVAS programme: A secondary analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 12, p. 2707, doi. 10.1111/dom.14525
- By:
- Publication type:
- Article
Potential kidney protection with liraglutide and semaglutide: Exploratory mediation analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 9, p. 2058, doi. 10.1111/dom.14443
- By:
- Publication type:
- Article
The effects of canagliflozin on heart failure and cardiovascular death by baseline participant characteristics: Analysis of the CREDENCE trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 7, p. 1652, doi. 10.1111/dom.14386
- By:
- Publication type:
- Article
Variability in estimated glomerular filtration rate and the risk of major clinical outcomes in diabetes: Post hoc analysis from the ADVANCE trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 6, p. 1420, doi. 10.1111/dom.14351
- By:
- Publication type:
- Article
The effects of dipeptidyl peptidase‐4 inhibitors on kidney outcomes.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 3, p. 763, doi. 10.1111/dom.14281
- By:
- Publication type:
- Article
Inter‐individual variability in atrasentan exposure partly explains variability in kidney protection and fluid retention responses: A post hoc analysis of the SONAR trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 561, doi. 10.1111/dom.14252
- By:
- Publication type:
- Article
Sodium‐glucose co‐transporter‐2 inhibitors with and without metformin: A meta‐analysis of cardiovascular, kidney and mortality outcomes.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 382, doi. 10.1111/dom.14226
- By:
- Publication type:
- Article
Sodium‐glucose co‐transporter‐2 inhibition and ocular outcomes in patients with type 2 diabetes: A systematic review and meta‐analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 1, p. 252, doi. 10.1111/dom.14197
- By:
- Publication type:
- Article
Effects of canagliflozin on initiation of insulin and other antihyperglycaemic agents in the CANVAS Program.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 11, p. 2199, doi. 10.1111/dom.14143
- By:
- Publication type:
- Article
The effect of canagliflozin on amputation risk in the CANVAS program and the CREDENCE trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 10, p. 1753, doi. 10.1111/dom.14091
- By:
- Publication type:
- Article
Clinical outcomes with canagliflozin according to baseline body mass index: results from post hoc analyses of the CANVAS Program.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 4, p. 530, doi. 10.1111/dom.13920
- By:
- Publication type:
- Article
Effect of SGLT2 inhibitors on cardiovascular, renal and safety outcomes in patients with type 2 diabetes mellitus and chronic kidney disease: A systematic review and meta‐analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 5, p. 1237, doi. 10.1111/dom.13648
- By:
- Publication type:
- Article
New clinical trial designs for establishing drug efficacy and safety in a precision medicine era.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, p. 14, doi. 10.1111/dom.13417
- By:
- Publication type:
- Article
Baseline characteristics and enrichment results from the SONAR trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 8, p. 1829, doi. 10.1111/dom.13315
- By:
- Publication type:
- Article
Rationale and protocol of the Study Of diabetic Nephropathy with AtRasentan (SONAR) trial: A clinical trial design novel to diabetic nephropathy.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 6, p. 1369, doi. 10.1111/dom.13245
- By:
- Publication type:
- Article
Linagliptin and its effects on hyperglycaemia and albuminuria in patients with type 2 diabetes and renal dysfunction: the randomized MARLINA- T2D trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 11, p. 1610, doi. 10.1111/dom.13041
- By:
- Publication type:
- Article
Optimizing the analysis strategy for the CANVAS Program: A prespecified plan for the integrated analyses of the CANVAS and CANVAS-R trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 7, p. 926, doi. 10.1111/dom.12924
- By:
- Publication type:
- Article
The effects of atrasentan on urinary metabolites in patients with type 2 diabetes and nephropathy.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 5, p. 749, doi. 10.1111/dom.12864
- By:
- Publication type:
- Article
Comparison of exposure response relationship of atrasentan between North American and Asian populations.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 4, p. 545, doi. 10.1111/dom.12851
- By:
- Publication type:
- Article
Rationale, design and baseline characteristics of the CANagliflozin cardioVascular Assessment Study-Renal ( CANVAS-R): A randomized, placebo-controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 3, p. 387, doi. 10.1111/dom.12829
- By:
- Publication type:
- Article
Impact of SGLT2 inhibitors on the kidney in people with type 2 diabetes and severely increased albuminuria.
- Published in:
- Expert Review of Clinical Pharmacology, 2022, v. 15, n. 7, p. 827, doi. 10.1080/17512433.2022.2108402
- By:
- Publication type:
- Article
Dipeptidyl peptidase-4 inhibition with linagliptin and effects on hyperglycaemia and albuminuria in patients with type 2 diabetes and renal dysfunction: Rationale and design of the MARLINA–T2D<sup>™</sup> trial.
- Published in:
- Diabetes & Vascular Disease Research, 2015, v. 12, n. 6, p. 455, doi. 10.1177/1479164115579002
- By:
- Publication type:
- Article
Effects of SGLT2 inhibitors on cardiovascular outcomes.
- Published in:
- Diabetes & Vascular Disease Research, 2012, v. 9, n. 2, p. 117, doi. 10.1177/1479164112441190
- By:
- Publication type:
- Article
Establishing a clinical trials network in nephrology: experience of the Australasian Kidney Trials Network.
- Published in:
- Kidney International, 2014, v. 85, n. 1, p. 23, doi. 10.1038/ki.2013.391
- By:
- Publication type:
- Article
The Authors Reply:.
- Published in:
- Kidney International, 2013, v. 84, n. 3, p. 622, doi. 10.1038/ki.2013.241
- By:
- Publication type:
- Article
Intensive glucose control improves kidney outcomes in patients with type 2 diabetes.
- Published in:
- Kidney International, 2013, v. 83, n. 3, p. 517, doi. 10.1038/ki.2012.401
- By:
- Publication type:
- Article
Circulating bone morphogenetic protein-7 and transforming growth factor-β1 are better predictors of renal end points in patients with type 2 diabetes mellitus.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Circulating bone morphogenetic protein-7 and transforming growth factor-β1 are better predictors of renal end points in patients with type 2 diabetes mellitus.
- Published in:
- Kidney International, 2013, v. 83, n. 2, p. 278, doi. 10.1038/ki.2012.383
- By:
- Publication type:
- Article
Routine blood pressure lowering and intensive glucose control in patients with Type 2 diabetes: the ADVANCE trial.
- Published in:
- Expert Review of Endocrinology & Metabolism, 2009, v. 4, n. 2, p. 111, doi. 10.1586/17446651.4.2.111
- By:
- Publication type:
- Article
Mortality in dialysis patients may not be associated with ESA dose: a 2-year prospective observational study.
- Published in:
- BMC Nephrology, 2012, v. 13, n. 1, p. 40, doi. 10.1186/1471-2369-13-40
- By:
- Publication type:
- Article
Emily Atkins and Vlado Perkovic, the authors of the article, comment.
- Published in:
- Australian Prescriber, 2019, v. 42, n. 6, p. 181
- By:
- Publication type:
- Article
Blood pressure: at what level is treatment worthwhile?
- Published in:
- Australian Prescriber, 2019, v. 42, n. 4, p. 127, doi. 10.18773/austprescr.2019.038
- By:
- Publication type:
- Article
The impact of the COVID‐19 pandemic on medical education.
- Published in:
- Medical Journal of Australia, 2020, v. 213, n. 7, p. 334, doi. 10.5694/mja2.50762
- By:
- Publication type:
- Article
The impact of the COVID-19 pandemic on medical education.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Reducing cardiovascular risk in people with diabetes and kidney disease.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Guideline for the diagnosis and management of hypertension in adults - 2016.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Is it time for Medi-change?
- Published in:
- 2014
- By:
- Publication type:
- Opinion
Effects of Intensive Blood Pressure Lowering on Cardiovascular and Renal Outcomes: A Systematic Review and Meta-Analysis.
- Published in:
- PLoS Medicine, 2012, v. 9, n. 8, p. 1, doi. 10.1371/journal.pmed.1001293
- By:
- Publication type:
- Article
The Relationship between Proteinuria and Coronary Risk: A Systematic Review and Meta-Analysis.
- Published in:
- PLoS Medicine, 2008, v. 5, n. 10, p. 1486, doi. 10.1371/journal.pmed.0050207
- By:
- Publication type:
- Article
How many Australian deaths from heart disease and stroke could be avoided by a small reduction in population cholesterol levels?
- Published in:
- Nutrition & Dietetics, 2009, v. 66, n. 3, p. 158, doi. 10.1111/j.1747-0080.2009.01360.x
- By:
- Publication type:
- Article
Association Between Circulating GDF-15 and Cardio-Renal Outcomes and Effect of Canagliflozin: Results From the CANVAS Trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Sodium-Glucose Cotransporter 2 Inhibition for the Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Socioeconomic Disadvantage and Kidney Disease in the United States, Australia, and Thailand.
- Published in:
- American Journal of Public Health, 2008, v. 98, n. 7, p. 1306, doi. 10.2105/AJPH.2007.116020
- By:
- Publication type:
- Article
Review: Revascularization and medical treatment may be similar in atherosclerotic renal artery stenosis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Effects of Antiplatelet Therapy on Mortality and Cardiovascular and Bleeding Outcomes in Persons With Chronic Kidney Disease.
- Published in:
- Annals of Internal Medicine, 2012, v. 156, n. 6, p. 445, doi. 10.7326/0003-4819-156-6-201203200-00007
- By:
- Publication type:
- Article